Squarepoint Ops LLC Agios Pharmaceuticals, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 27,000 shares of AGIO stock, worth $929,340. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,000

Previous 6,622 307.73%

Holding current value

$929,340

Previous $285,000 320.7%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$27.55 - $48.83 $2.9 Million - $5.15 Million	-105,444 Reduced 94.09%	6,622 $285,000
Q1 2024 May 15, 2024	BUY	$21.32 - $34.81 $1.67 Million - $2.72 Million	78,140 Added 230.32%	112,066 $3.28 Million
Q4 2023 Feb 14, 2024	BUY	$19.97 - $24.53 $677,502 - $832,204	33,926 New	33,926 $755,000
Q1 2023 May 15, 2023	SELL	$21.74 - $30.93 $321,208 - $456,990	-14,775 Reduced 57.42%	10,956 $251,000
Q4 2022 Feb 14, 2023	BUY	$24.81 - $31.52 $212,448 - $269,905	8,563 Added 49.88%	25,731 $722,000
Q3 2022 Nov 14, 2022	SELL	$19.51 - $34.14 $1.64 Million - $2.87 Million	-84,023 Reduced 83.03%	17,168 $486,000
Q2 2022 Aug 15, 2022	BUY	$17.06 - $31.42 $1.14 Million - $2.1 Million	66,819 Added 194.4%	101,191 $2.24 Million
Q1 2022 May 16, 2022	SELL	$26.68 - $34.81 $220,296 - $287,426	-8,257 Reduced 19.37%	34,372 $1 Million
Q4 2021 Feb 14, 2022	BUY	$29.58 - $49.78 $1.26 Million - $2.12 Million	42,629 New	42,629 $1.4 Million
Q1 2021 May 17, 2021	SELL	$44.23 - $57.5 $4.58 Million - $5.95 Million	-103,454 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$33.21 - $46.54 $928,285 - $1.3 Million	-27,952 Reduced 21.27%	103,454 $4.48 Million
Q3 2020 Nov 16, 2020	BUY	$33.87 - $55.93 $4.45 Million - $7.35 Million	131,406 New	131,406 $4.6 Million
Q2 2020 Aug 14, 2020	SELL	$34.45 - $53.48 $848,503 - $1.32 Million	-24,630 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$31.52 - $53.81 $2.76 Million - $4.72 Million	-87,635 Reduced 78.06%	24,630 $874,000
Q4 2019 Feb 14, 2020	BUY	$30.08 - $50.59 $3.38 Million - $5.68 Million	112,265 New	112,265 $5.36 Million
Q3 2019 Nov 14, 2019	SELL	$32.4 - $49.58 $566,254 - $866,509	-17,477 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$46.17 - $68.1 $806,913 - $1.19 Million	17,477 New	17,477 $872,000
Q1 2019 May 15, 2019	SELL	$45.92 - $67.67 $265,509 - $391,267	-5,782 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$42.73 - $76.53 $1.05 Million - $1.89 Million	-24,652 Reduced 81.0%	5,782 $267,000
Q3 2018 Nov 14, 2018	BUY	$71.67 - $91.95 $1.45 Million - $1.86 Million	20,253 Added 198.93%	30,434 $2.35 Million
Q2 2018 Aug 14, 2018	BUY	$73.22 - $99.55 $745,452 - $1.01 Million	10,181 New	10,181 $858,000
Q1 2018 May 15, 2018	SELL	$59.83 - $86.53 $1.02 Million - $1.48 Million	-17,088 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$52.12 - $72.33 $673,755 - $935,009	12,927 Added 310.67%	17,088 $977,000
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $228,397 - $279,286	4,161	4,161 $278,000

Others Institutions Holding AGIO

# of Institutions

232

Shares Held

58.1M

Call Options Held

403K

Put Options Held

469K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.89B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Agios Pharmaceuticals, Inc. Transaction History